4th Annual Rare and Genetic Kidney Disease Drug Development Summit

The 4th Annual Rare and Genetic Kidney Disease Drug Development Summit is dedicated to the development of therapeutic treatments in PKD, IgA, FSGS, Alport Syndrome and more.

The 4th Annual Rare and Genetic Kidney Disease Drug Development Summit covers topics such as:

• Applications of microRNA as a treatment for ADPKD, Alport Syndrome, FSGS, IgAN and more
• New diagnostic tools beyond creatinine, proteinuria, and total kidney
• Evidence to achieve FDA’s full approval of a biologic and demonstrate long-term efficacy
• Disease modelling of genetic kidney diseases through stem cell-derived kidney organoids

The 4th Annual Rare and Genetic Kidney Disease Drug Development Summit might be held in Nov 2024.